by The global Urometer market size is expected to be worth around US$ 839.9 million by 2030, according to a new report by Vision Research Reports.
The global Urometer market size was valued at US$ 557.7 million in 2020 and is anticipated to grow at a CAGR of 7.8% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39037
Growth Factors
Increasing efforts by numerous nonprofit organizations and regional companies to promote awareness about incontinence care across the world are likely to stimulate product demand, thereby indirectly fueling the market growth.
Healthcare professionals, such as urologists, gynecologists, urogynecologists, physiotherapists, primary care practitioners, nurses, and other professional organizations, have actively partaken to increase awareness about continence in all care settings. Such efforts are anticipated to enhance the administration of incontinence treatment. Thus, increased awareness, rising implementation of appropriate reimbursement policies, a surge in R&D expenditures are expected to boost the market growth.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 839.9 million by 2030 |
| Growth Rate | CAGR of 7.8% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Application, End user |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | BD; Teleflex, Inc.; Cardinal Health; Medline Industries, Inc.;ConvaTec, Inc.; Forlong Medical Co.Ltd.; Hitec Medical Co. Ltd.; Laborie; Fannin; Observe Medical ASA |
By Product Analysis
On the basis of product, the market is segmented into 100 ml, 200 ml, 400 ml, 450 ml, and 500 ml. The 500ml product segment held the largest market share of over 30% in 2020. It is expected to grow at the highest CAGR during the forecast period due to the rising incidence of urine incontinence, urine bladder cancer, and associated urological disorders.
A rising volume of prostate surgeries, bladder, urology & gynecology surgeries, removal of kidney stones, and other long surgical procedures are leading to the increasing demand for 500 ml urometers. However, increased risk of Urinary Tract Infections (UTIs) and skin irritation associated with the usage of drainage bags and urometers may restrain the market growth.
By Application Analysis
On the basis of application, the market is segmented into operative procedures, emergency trauma, palliative care, and others. The operative procedures segment dominated the market with a revenue share of 37.3% in 2020.
The increasing number of surgical procedures necessitating post-operative care is expected to boost the product demand during the forecast period. Moreover, the rising occurrence of urological illnesses and the growing geriatric population support market growth.
The palliative care segment is anticipated to witness a considerable CAGR from 2021 to 2028. The increasing geriatric population in developed countries with severe, progressive, or incurable illnesses is a crucial factor driving the palliative care segment.
A growing focus on hospice comfort and control systems is opening up new opportunities for key players. Similarly, a surge in investments in equipping hospitals and palliative care centers with dedicated teams contributes to the growth of the segment.
By End-user Analysis
On the basis of end-user, the market is segmented into hospitals, clinics, home healthcare, and others. The hospitals’ segment held the largest revenue share of over 43% in 2020. The growing volume of surgical procedures and cases of End-stage Renal Diseases (ESRD) are amongst the major drivers of the segment.
With rising prevalence in ESRD, the product demand is growing. Moreover, the increase in hospital admissions, especially the old patients due to the recent outbreak of COVID-19, is also anticipated to propel the segment growth over the forecast period. Older patients generally require urometer on hospital admissions to avoid frequent movement.
The home care segment is anticipated to witness the fastest growth over the forecast period. The emergence of home healthcare as a more cost-effective substitute to hospitalization is likely to boost the market growth over the forecast years.
By Regional Analysis
Asia Pacific dominated the global market in 2020 with a revenue share of more than 29.5% and is expected to witness the fastest CAGR over the forecast period. The presence of a large population base and rising patient pool in countries, such as China and India, are major factors driving the market growth.
North America is expected to witness a moderate growth rate over the forecast period. The market in North America is mainly driven by the rising incidence of urological diseases, such as UI, urinary retention, bladder obstruction Benign Prostate Hyperplasia (BPH), and bladder cancer.
Key Players
- BD
- Teleflex, Inc.
- Cardinal Health
- Medline Industries, Inc.
- ConvaTec Inc.
- Forlong Medical Co., Ltd.
- Hitec Medical Co., Ltd.
- Laborie
- Fannin
- Observe Medical ASA
Market Segmentation
- By Product
- 100 ml
- 200 ml
- 400 ml
- 450 ml
- 500 ml
- By Application
- Operative Procedures
- Emergency Trauma
- Palliative Care
- Others
- By End-user
- Hospital
- Clinics
- Home Healthcare
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Urometer Market, By Product
7.1. Urometer Market, by Product, 2021-2030
7.1.1. 100 ml
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. 200 ml
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. 400 ml
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. 450 ml
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. 500 ml
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Urometer Market, By Application
8.1. Urometer Market, by Application, 2021-2030
8.1.1. Operative Procedures
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Emergency Trauma
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Palliative Care
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Urometer Market, By End User
9.1. Urometer Market, by End User, 2021-2030
9.1.1. Hospital
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Urometer Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. BD
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Teleflex, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Cardinal Health
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medline Industries, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. ConvaTec Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Forlong Medical Co., Ltd.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hitec Medical Co., Ltd.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Laborie
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fannin
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Observe Medical ASA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39037
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
